Clinical Trials

Cancer Type: GI Cancers


Pro-248

FOLFOX PGx: A Pilot Prospective Clinical Trial to use Personalized Medicine through Pharmacogenetics in the Treatment of Gastrointestinal Cancers

The purpose of this study is to determine if prospectively testing subjects for variations in genes involved in the pharmacologic disposition of the FOLFOX combination in patients with gastrointestinal malignancies is feasible.

Hospitals Offering This Trial: Lombardi/MedStar Georgetown Hospital; MedStar Montgomery Medical Center

Forms:

 

GI CANCER CONTACT

Karen Dorsch-Vogel, RN
Email: kd252@georgetown.edu
Phone: 202-687-6974